Veterinary Vaccines: A Global Strategic Business Report
San Jose, California (PRWEB) February 22, 2012
Follow us on LinkedIn – Veterinary vaccines are of vital importance with regard to animal health care. Growth in the veterinary vaccines market is primarily attributed to augmented public awareness and technological innovations, in particular DNA-related vaccines. DNA-related vaccines and other newly developed vaccines are considered advantageous over traditional vaccines in terms of production volumes and immune response. Growing demand for the vaccines and increased vulnerability to the diseases such as bird flu, avian influenza, anthrax, and other viral and bacterial infections, is steering the demand for veterinary vaccines in the emerging Asia-Pacific regions. Moreover, the altering patterns of diseases among animals and increased development of resistance to currently used antimicorbials is compelling manufacturers to invest heavily in new product developments.
As stated by the new market research report on Veterinary Vaccines, Europe represents the largest market for veterinary vaccines, followed by the US. Companion animal vaccines segment in most economies is expected to register healthy growth in the near future owing to the rise in product developments and general aging factor in the pet population. Moreover the burgeoning concept of pet insurance is stimulating pet owners to spend more on routine health care and preventive treatments. Pest and disease control and general animal health aspects are gaining more importance in the animal management programs, which in turn predict a brighter future for the veterinary vaccines market. Livestock vaccines represent the largest product group in the veterinary vaccines market. Developments in the fields of life sciences and biotechnology are expected to support the launch of new advanced products for various needs.
Key players in the marketplace include Bayer HealthCare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd, Lohmann Animal Health, Merck Animal Health, Merial Ltd., Pfizer Inc., Fort Dodge Animal Health, Protein Sciences Corporation, Virbac Corporation, among others.
The research report titled "Veterinary Vaccines: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. This study provides market estimates and projections in terms of annual revenues (in US$ Million) for regional markets including US, Europe and Rest of World markets. Product segments covered in the report include Companion Animals Vaccines (Canine Vaccines, and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, and Equine Vaccines among other animal vaccines).
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/